James Stillman Hanson

Overview

James Stillman Hanson received $5M in total compensation, including $169K in salary, at G1 Therapeutics in 2018.

Source: SEC filing on April 30, 2019.

Related executives

We found nine more executives who work or worked at G1 Therapeutics.

John Bailey

G1 Therapeutics

Chief Executive Officer

Jennifer Moses

G1 Therapeutics

Chief Financial Officer

Mark Avagliano

G1 Therapeutics

Chief Business Officer

Mark Velleca

G1 Therapeutics

Chief Executive Officer

Soma Gupta

G1 Therapeutics

Chief Commercial Officer

Rajesh Malik

G1 Therapeutics

Chief Medical Officer

John Demaree

G1 Therapeutics

Chief Commercial Officer

Barclay Phillips

G1 Therapeutics

Chief Financial Officer

News

You may also like